El Servicio de Anestesiología, Reanimación y Terapéutica del Dolor del Hospital Universitario de Bellvitge ha participado en el estudio internacional ALICE (The Aetiology and Prevalence of Anaemia ...
Read moreA CNIC study reveals that neutrophils—a type of immune cell—are less aggressive at night, explaining why nighttime heart attacks are less severe than those occurring during the day
Read morePublished in The New England Journal of Medicine, findings from the investigator-initiated phase 3 CLL17 randomized trial demonstrate that limited duration targeted therapy for chronic lymphocytic leu...
Read moreHan identificado varios fármacos ya aprobados por las agencias reguladoras que podrían convertirse en un nuevo tratamiento para la anemia de Diamond-Blackfan (DBA), una enfermedad rara caracterizada...
Read moreResearchers from the National Center for Genomic Analysis (CNAG) have published the first cellular atlas of inflammation, a comprehensive database that analysed more than 6.5 million blood cells from ...
Read moreTebubio is pleased to announce its collaboration with the Belgian Red Cross, a leading European blood establishment, to broaden access to Human Platelet Lysate (hPL) sourced exclusively from voluntary...
Read moreDemuestran que la administración de hierro intravenoso, añadida a la profilaxis oral habitual, aumenta la concentración de hemoglobina materna antes del parto en mujeres embarazadas con deficiencia...
Read moreExtracellular vesicles (EVs) transport proteins, lipids and nucleic acids. Therefore, they are of great interest as sources of biomarkers and as mediators of intercellular communication. However, when...
Read moreCientíficos andaluces logran una «huella molecular» en glóbulos blancos que ofrece mejoras a ser consideradas en los próximos años
Read moreA multidisciplinary Clínic-IDIBAPS team, part of the Clínic Barcelona Comprehensive Cancer Centre (4CB), has published phase 2 results of the CAR-T ARI-0001 (varnimcabtagene autoleucel) for treating...
Read moreEl hallazgo, conseguido en el estudio CORDIOPREV, mejora la identificación de personas en riesgo y refuerza la prevención personalizada mediante dieta mediterránea.
Read moreOryzon Genomics ha anunciado hoy que la Agencia Europea del Medicamento ha aprobado su Solicitud de Autorización de Ensayo Clínico para iniciar un ensayo clínico de Fase II de iadademstat, el inhi...
Read more